NASDAQ:MIRM | Free Cash Flow | Mirum Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$228.76M$664,000.00-$229.43M
2025-12-31$6.07M$600,000.00$5.47M
2025-03-31-$1.96M$41,000.00-$2M
2024-12-31-$5.07M$20,000.00-$5.09M
2024-03-31$15.21M$13,000.00$15.2M
2023-12-31-$16.62M$0.00-$16.62M
2023-03-31-$18.77M$41,000.00-$18.82M
2022-12-31-$34.27M$242,000.00-$34.51M
2022-03-31-$39.67M$0.00-$39.67M
2021-12-31-$33.15M$3,000.00-$33.15M-57.61%
2021-03-31-$25.21M$3,000.00-$25.21M
2020-12-31-$36.28M$28,000.00-$36.31M
2020-03-31-$18.35M$98,000.00-$18.45M
2019-12-31-$13.7M$67,000.00-$13.77M
2019-03-31-$2.43M$44,000.00-$2.47M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$55.83M$954,000.00$54.87M
2024-12-31$10.33M$993,000.00$9.33M
2023-12-31-$70.94M$109,000.00-$71.05M
2022-12-31-$120.14M$278,000.00-$120.41M
2021-12-31-$132.76M$24,000.00-$132.78M
2020-12-31-$89.08M$225,000.00-$89.3M
2019-12-31-$39.36M$281,000.00-$39.64M